TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Withdrawal signs and symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Urges to smoke (craving)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cortisol release response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: mean heart rate post-stick
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: mean crying time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean sleep disruption time
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: alterations of local rs-activity within neuroanatomical pathways
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: increased rs-FC between regions within the noradrenergic pathway
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: modulation of local rs-activity within the dopaminergic pathway
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Child consumption of non-core foods
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: strictly unilateral sensory block
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: strictly unilateral sympathetic block
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction of non-perfusion area
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Shortening of retinal circulation time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Formation of collateral circulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of substandard samples
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Occurrence rate of esophageal stricture
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Mean value of esophageal stricture time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Times of balloon dilatation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Improvement according to the Treatment Benefit Scale (TBS)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: asthma-symptom-free days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: urgent asthma-related clinical visits
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: quality of life of BEH caretakers
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Number of days with swelling
Endpoint domain: Adverse events/effects
Primary endpoint: Number of analgesic drugs taken
Endpoint domain: Adverse events/effects
Primary endpoint: Community diversity during pad use
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Choroidal blood flow increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: right pulmonary blood flow difference
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Reduction in mean nuclear volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: No mitosis observed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Composite of cardiovascular death and cardiovascular hospital admissions
Endpoint domain: Mortality/survival
Primary endpoint: adjusted FEV1 at 12 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: evening PEF
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: P1 amplitude and implicit time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Comparability of nonbronchoscopic lavage to bronchoscopic lavage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pharmacokinetic profile of octreotide
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: FiO2 improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: FiO2/oxygen ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pulse oximetry
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: BILAG-defined response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SEP-2 success rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SEP-3 success rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients with undetectable viral load (< 80 copies/ml)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of compensated recurrences of low back pain
Endpoint domain: Adverse events/effects
Primary endpoint: Duration of recurrences of low back pain
Endpoint domain: Adverse events/effects
Primary endpoint: Postpartum Hemorrhage (PPH) incidence
Endpoint domain: Adverse events/effects
Primary endpoint: Threshold change in hearing (dB)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frustration score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Limitation on social activities
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Composite satisfaction score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: PPI-VAS scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Non-adherence
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Average delay to return to normal activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Local wound problems in terms of scarring or scar tenderness
Endpoint domain: Adverse events/effects
Primary endpoint: Adequacy of bone for dental implant placement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to relapse (TTR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Healing without severe adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Improvement in dietary behaviors
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: long-term local tumor control
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: NMD increase after treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Relative changes in mean flow volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Relative changes in mean flow velocity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: nonfatal myocardial infarction
Endpoint domain: Adverse events/effects
Primary endpoint: H(max)/M(max) percent ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: total parental attitude score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: scoring errors
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Continuous quit rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Detection of H. pylori infection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Presence of gastric atrophy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Severity of H. pylori-related gastric inflammation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Prevalence of hypertriglyceridaemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Child food insecurity alleviation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Social stigmatization minimization
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Hair cortisol concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fluoride levels in fingernails and toenails
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Functioning and quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: total CRF
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: symptom burden
Endpoint domain: Adverse events/effects
Primary endpoint: 15D total score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: intraobserver reliability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: interobserver reliability for paraspinal tenderness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: RS-fMRI connectivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: regional brain activity during DWM retrieval
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: response speed to DWM task
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: continence re-operation rate
Endpoint domain: Adverse events/effects
Primary endpoint: groin pain/discomfort rate
Endpoint domain: Adverse events/effects
Primary endpoint: steps walked per day
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Core temperature decrease
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Performance in the six minute walk test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Performance in the timed up‐and‐go test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intermolar width decrease
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients achieving HbA1c <= 7%
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Maximal plasma salbutamol concentration (CMAX)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Average plasma salbutamol concentration (CAV)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: severe exacerbation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Perianal itching duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sudden cardiac death (SCD) rate
Endpoint domain: Mortality/survival
Primary endpoint: SCD-free survival
Endpoint domain: Mortality/survival
Primary endpoint: Change in muscle strength scores in the right quadriceps
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Body fat percentage changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total subjective symptom scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Reductions in endometriotic foci
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in SUA levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: WOSI
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: limiting factor in abduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to onset of oral mucositis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Severity of radiation stomatitis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain level in patients
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean decrease in ICP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: duration of effect
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: PGWBI score improvement
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Risk of developing OPLL
Endpoint domain: Mortality/survival
Primary endpoint: Virologic outcome at week 52
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Detection rate of psychological distress
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pregnancy Rate (PR) per treatment cycle
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Incidence of ectopic pregnancy
Endpoint domain: Adverse events/effects
Primary endpoint: Reduction in Hb concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Reduction in gametocyte carriage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Occupational sedentary time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Occupational standing time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of recovery at 24 hours
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Bowel cleansing grades
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Serum electrolyte levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Tolerance of solution taste
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Percentage of gamma delta T cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Absolute numbers of circulating gamma delta T cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Psychiatric comorbidity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Infection vulnerability
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: MEMS-based adherence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MMAS scores of forgetting medication
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Carotid-femoral pulse wave velocity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Thyroid size reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: medical services utilisation
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Frequency of severe reactions to platelets
Endpoint domain: Adverse events/effects
Primary endpoint: Prevalence of hirsutism
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Cosmetic outcome of wound closure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Parents' evaluation using Visual Analogue Scale (VAS)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Mean defervescence time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical benefit in patients at high risk of recurrent RCC
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Mean pain intensity at rest
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: proper glycemic control
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Adherence to CONSORT statement
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Complete remission of signs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Systemic side-effects
Endpoint domain: Adverse events/effects
Primary endpoint: Total ATG dose per patient
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Mean cumulative daily dose of ATG
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Cost of treatment
Endpoint domain: Resource use
Endpoint subdomain: Societal/carer burden
Primary endpoint: Addressed psychosocial priorities during visit
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Clinical action on psychosocial priorities
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Post visit information received for psychosocial priorities
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: mental health component score of quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: self-reported weekly exercise levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Complete mucosal healing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: total axial rotation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Self-reported point abstinence
Endpoint domain: Mortality/survival
Primary endpoint: Electroencephalographic recordings of alpha and beta power
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Deactivation at night as measured by self-rating scales
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: 12-month target lesion failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Improvement of immune responses
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Improvement of upper respiratory tract physiology
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Subjective assessment of symptoms on VAS
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Plasma concentration of LMW icodextrin metabolites G2-G7
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Absorption of icodextrin from the peritoneal cavity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasma alpha-amylase activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of clinically acceptable intubating conditions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: tolerability of neoadjuvant sorafenib treatment
Endpoint domain: Adverse events/effects
Primary endpoint: Lower Extremity Functional Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: time to oral intake resumption
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: convalescence period
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: sustained 12-month abstinence rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 7-day point prevalence for abstinence at 12-month follow-up
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median change from baseline in BCVA (ETDRS lines)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: clinician compliance with care guidelines
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Total narcotic usage
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Use of oral narcotics after discharge
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: recurrence-free period
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Incidence of thrombo-embolic events requiring hospital admission
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of bleeding events requiring hospital admission
Endpoint domain: Adverse events/effects
Primary endpoint: Bleeding after 24 hours of the procedure
Endpoint domain: Adverse events/effects
Primary endpoint: Alveolar NO concentration (CANO)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement on the Groton Maze Learning Task
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Erectile function domain score at IIEF
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Arterial inflow to cavernous arteries
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: T and FT levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: mean FVC
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: mean MVV
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: fewer drug prescriptions
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: fewer referrals to the ED
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: cost of a consultation
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Aliskiren plasma concentration (maximum plasma concentration and area under the plasma concentration‐time curve)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HF biomarkers (B‐type natriuretic peptide, ejection fraction)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: API scores reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CGI-I difference
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Primary outcome event
Endpoint domain: Mortality/survival